Business Description
Nahdi Medical Co
ISIN : SA15HG521213
Compare
Compare
Traded in other countries / regions
4164.Saudi IPO Date
2022-03-22Description
Nahdi Medical Co is engaged in the wholesale and retail trading of cosmetics, pharmaceutical products, special and healthy foods, and medical equipment. It has two operating segments: Front Shop and Pharma.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.69 | |||||
Equity-to-Asset | 0.35 | |||||
Debt-to-Equity | 0.68 | |||||
Debt-to-EBITDA | 1.03 | |||||
Interest Coverage | 10.35 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 3.71 | |||||
Beneish M-Score | -1.99 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 5.8 | |||||
3-Year EBITDA Growth Rate | 2.9 | |||||
3-Year EPS without NRI Growth Rate | -1.9 | |||||
3-Year FCF Growth Rate | -19.9 | |||||
3-Year Book Growth Rate | 6.9 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank | 5 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 6.79 |
Momentum Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 82.15 | |||||
9-Day RSI | 66.72 | |||||
14-Day RSI | 56.4 | |||||
3-1 Month Momentum % | -10.82 | |||||
6-1 Month Momentum % | -4.76 | |||||
12-1 Month Momentum % | -27.19 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.34 | |||||
Quick Ratio | 0.57 | |||||
Cash Ratio | 0.4 | |||||
Days Inventory | 118.71 | |||||
Days Sales Outstanding | 8.49 | |||||
Days Payable | 92.37 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Yield % | 6.01 | |||||
Dividend Payout Ratio | 0.9 | |||||
3-Year Dividend Growth Rate | 34.3 | |||||
Forward Dividend Yield % | 6.44 | |||||
5-Year Yield-on-Cost % | 6.01 | |||||
Shareholder Yield % | 3.75 |
Profitability Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 37.11 | |||||
Operating Margin % | 8.73 | |||||
Net Margin % | 7.82 | |||||
EBITDA Margin % | 16.63 | |||||
FCF Margin % | 9.27 | |||||
OCF Margin % | 13.11 | |||||
ROE % | 31.17 | |||||
ROA % | 12.01 | |||||
ROIC % | 20.36 | |||||
3-Year ROIIC % | -3.06 | |||||
ROC (Joel Greenblatt) % | 25.62 | |||||
ROCE % | 21.03 | |||||
Years of Profitability over Past 10-Year | 5 |
GF Value Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 15.09 | |||||
Forward PE Ratio | 14.51 | |||||
PE Ratio without NRI | 15.1 | |||||
Price-to-Owner-Earnings | 11.52 | |||||
PS Ratio | 1.17 | |||||
PB Ratio | 4.67 | |||||
Price-to-Tangible-Book | 4.8 | |||||
Price-to-Free-Cash-Flow | 12.71 | |||||
Price-to-Operating-Cash-Flow | 8.99 | |||||
EV-to-EBIT | 13.88 | |||||
EV-to-EBITDA | 7.41 | |||||
EV-to-Revenue | 1.23 | |||||
EV-to-FCF | 12.89 | |||||
Price-to-GF-Value | 0.67 | |||||
Price-to-Graham-Number | 1.79 | |||||
Earnings Yield (Greenblatt) % | 7.21 | |||||
FCF Yield % | 7.87 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Nahdi Medical Co Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ï·¼) | 10,372.727 | ||
| EPS (TTM) (ï·¼) | 6.23 | ||
| Beta | 0.478 | ||
| 3-Year Sharpe Ratio | -1.45 | ||
| 3-Year Sortino Ratio | -1.46 | ||
| Volatility % | 20.02 | ||
| 14-Day RSI | 56.4 | ||
| 14-Day ATR (ï·¼) | 1.115635 | ||
| 20-Day SMA (ï·¼) | 92.2875 | ||
| 12-1 Month Momentum % | -27.19 | ||
| 52-Week Range (ï·¼) | 89.75 - 130.5 | ||
| Shares Outstanding (Mil) | 130 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Nahdi Medical Co Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Nahdi Medical Co Stock Events
| Event | Date | Price (ï·¼) | ||
|---|---|---|---|---|
| SAR 3.000000 Cash Dividend | 2026-03-30 | 107.50 (-0.46%) | ||
| SAR 2.600000 Cash Dividend | 2025-08-13 | 120.70 (-0.66%) | ||
| SAR 3.000000 Cash Dividend | 2025-03-18 | 117.20 (+0.00%) | ||
| SAR 2.500000 Cash Dividend | 2024-08-12 | 127.80 (-0.93%) |
Show
Entries
Nahdi Medical Co Frequently Asked Questions
What is Nahdi Medical Co(SAU:4164)'s stock price today?
The current price of SAU:4164 is ï·¼94.00. The 52 week high of SAU:4164 is ï·¼130.50 and 52 week low is ï·¼89.75.
When is next earnings date of Nahdi Medical Co(SAU:4164)?
The next earnings date of Nahdi Medical Co(SAU:4164) is .
Does Nahdi Medical Co(SAU:4164) pay dividends? If so, how much?
The Dividend Yield %  of Nahdi Medical Co(SAU:4164) is 6.01% (As of Today), Highest Dividend Payout Ratio of Nahdi Medical Co(SAU:4164) was 0.9. The lowest was 0.34. And the median was 0.84. The  Forward Dividend Yield % of Nahdi Medical Co(SAU:4164) is 6.44%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Nahdi Medical Co
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers